THE TRUTH ABOUT: 4 | History Defined

Tesla's Quality Score Tumbles, While Taiwan Semiconductor's Growth Rating Soars

While daily stock price moves tend to dominate headlines, shifts in fundamental ranking scores can often tell a deeper story about a company's trajectory. This week, Benzinga's proprietary Growth, Value, Quality and Momentum data revealed major swings among household names, from electric vehicles to pharmaceuticals and financials.

Benzinga · Aug 22, 2025

AbbVie's Patch Baldness Study Finds High Hair Coverage Rates With Investigational Drug Upadacitinib

AbbVie Inc. (NYSE:ABBV) on Thursday released topline results from the second of two pivotal studies of the Phase 3 UP-AA clinical program evaluating the safety and efficacy of upadacitinib (RINVOQ; 15 mg and 30 mg, once daily) in adult and adolescent patients with severe alopecia areata (AA) with a mean…

Benzinga · Aug 21, 2025

Sixth Circuit Rejects Associational Standing in Medicare Drug Pricing Challenge

An easy way to avoid the merits in the latest high-stake health care litigation.

Reason · Aug 9, 2025

AbbVie Stock Eyes Breakout as Pipeline and Profits Grow

AbbVie stock pops after strong Q2 earnings and raised guidance, as Skyrizi and Rinvoq offset Humira's decline and support a bullish outlook

MarketBeat · Jul 31, 2025

AbbVie Lifts Outlook, Eyes Parkinson's Assets As Next Growth Frontier

AbbVie Inc. (NYSE:ABBV) reported second-quarter 2025 sales of $15.42 billion on Thursday, beating the consensus of $14.98 billion. Sales increased 6.6% on a reported basis or 6.5% on an operational basis. The company reported adjusted earnings of $2.97, up 12.1% year over year and missing the consensus of $3.23.

Benzinga · Jul 31, 2025

Seven all-American products that are actually 'Made in Europe', set to be hit by US tariffs

Trump’s tariffs are aimed at ostensibly boosting US production and fostering a “local for locals” sensibility. Except, it turns out that several American product staples are actually... "Made in Europe"?

Euronews · Jul 31, 2025

Uber, Western Union, Live Nation Entertainment And A Health Care Stock On CNBC's 'Final Trades'

As investors navigate a volatile market landscape, attention turns to upcoming earnings reports from major companies, which could provide insights into broader economic trends. This earnings season, analysts and investors are closely watching key players like AbbVie, Uber, and Western Union for signs of growth and stability amid shifting market…

Benzinga · Jul 24, 2025

Boeing, Joby Aviation, Oracle And A Health Care Stock: CNBC's 'Final Trades'

The investment landscape is shifting as companies across various sectors demonstrate resilience and innovation, prompting investors to reassess their portfolios.

Benzinga · Jul 11, 2025

Why Is AbbVie Stock Trading Higher On Thursday?

IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation Inc., and AbbVie Inc. (NYSE:ABBV), on Thursday, announced an exclusive licensing agreement for IGI’s lead investigational asset, ISB 2001, developed using IGI’s proprietary BEAT protein platform, for oncology and autoimmune diseases.

Benzinga · Jul 10, 2025

Here's What to Expect From AbbVie's Next Earnings Report

AbbVie will release its second-quarter earnings later this month, and analysts anticipate a double-digit bottom-line growth.

Barchart · Jul 7, 2025